PIAS1 regulates CP2c localization and active promoter complex formation in erythroid cell-specific α-globin expression

Nucleic Acids Research

Volumn 38, Issue 16, 2010, Pages 5456-5471

  Kang, Ho Chul ^a   Chae, Ji Hyung ^a   Jeon, Jinseon ^a   Kim, Won ^a   Ha, Dae Hyun ^a   Shin, June Ho ^a   Kim, Chan Gil ^b   Kim, Chul Geun ^a  

^a Hanyang University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; DNA; MUTANT PROTEIN; PIAS1 PROTEIN; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CP2C; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HEMOGLOBIN ALPHA CHAIN; PROTEIN INHIBITOR OF ACTIVATED STAT; TCFCP2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ERYTHROID CELL; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR TRANSPORT; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RING FINGER MOTIF; RNA INTERFERENCE; SUMOYLATION; TRANSACTIVATION; TRANSCRIPTION REGULATION; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CELL NUCLEUS; CHEMISTRY; GENETICS; METABOLISM; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ALPHA-GLOBINS; ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; DNA-BINDING PROTEINS; ERYTHROID CELLS; HUMANS; MICE; PROMOTER REGIONS, GENETIC; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN INTERACTION DOMAINS AND MOTIFS; RNA INTERFERENCE; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 77956518725     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq286     Document Type: Article

References (49)

1. Veljkovic,J. and Hansen,U. (2004) Lineage-specific and ubiquitous biological roles of the mammalian transcription factor LSF. Gene, 343, 23-40.
2. Jane,S.M., Ney,P.A., Vanin,E.F., Gumucio,D.L. and Nienhuis,A.W. (1992) Identification of a stage selector element in the human gamma-globin gene promoter that fosters preferential interaction with the 5′ HS2 enhancer when in competition with the beta-promoter. EMBO J., 11, 2961-2969.
3. Zhou,W., Clouston,D.R., Wang,X., Cerruti,L., Cunningham,J.M. and Jane,S.M. (2000) Induction of human fetal globin gene expression by a novel erythroid factor, NF-E4. Mol. Cell. Biol., 20, 7662-7672.
4. Zhou,W., Zhao,Q., Sutton,R., Cumming,H., Wang,X., Cerruti,L., Hall,M., Wu,R., Cunningham,J.M. and Jane,S.M. (2004) The role of p22 NF-E4 in human globin gene switching. J. Biol. Chem., 279, 26227-26232.
5. Bosè,F., Fugazza,C., Casalgrandi,M., Capelli,A., Cunningham,J.M., Zhao,Q., Jane,S.M., Ottolenghi,S. and Ronchi,A. (2006) Functional interaction of CP2 with GATA-1 in the regulation of erythroid promoters. Mol. Cell. Biol., 26, 3942-3954.
6. Bruni,P., Minopoli,G., Brancaccio,T., Napolitano,M., Faraonio,R., Zambrano,N., Hansen,U. and Russo,T. (2002) Fe65, a ligand of the Alzheimer's beta-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression. J. Biol. Chem., 277, 35481-35488.
7. Zambrano,N., Minopoli,G., Candia,P. and Russo,T. (1998) The [65Fe] adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J. Biol. Chem., 273, 20128-20133.
8. Barnhart,K.M., Kim,C.G., Banerji,S.S. and Sheffery,M. (1988) Identification and characterization of multiple erythroid cell proteins that interact with the promoter of the murine alpha-globin gene. Mol. Cell. Biol., 8, 3215-3226.
9. Kim,C.G., Barnhart,K.M. and Sheffery,M. (1988) Purification of multiple erythroid cell proteins that bind the promoter of the α-globin gene. Mol. Cell. Biol., 8, 4270-4281.
10. Kim,C.G., Swendeman,S.L., Barnhart,K.M. and Sheffery,M. [1990(] Promoter-elements and erythroid cell nuclear factors that regulate α-globin gene transcription in vitro. Mol. Cell. Biol., 10, 5958-5966.
11. Lim,L.C., Fang,L., Swendeman,S.L. and Sheffery,M. (1993) Characterization of the molecularly cloned murine alpha-globin transcription factor CP2. J. Biol. Chem., 268, 18008-18017.
12. Lim,L.C., Swendeman,S.L. and Sheffery,M. (1992) Molecular cloning of the alpha-globin transcription factor CP2. Mol. Cell. Biol., 12, 828-835.
13. Chae,J.H., Lee,Y.H. and Kim,C.G. (1999) Transcription factor [2CP] is crucial in hemoglobin synthesis during erythroid terminal differentiation in vitro. Biochem. Biophys. Res. Commun., 263, 580-583.
14. Kang,H.C., Chae,J.H., Lee,Y.H., Park,M.A., Shin,J.H., Kim,S.H., Ye,S.K., Cho,Y.S., Fiering,S. and Kim,C.G. (2005) Erythroid cell-specific alpha-globin gene regulation by the CP2 transcription factor family. Mol. Cell. Biol., 25, 6005-6020.
15. Chae,J.H., Kang,H.C. and Kim,C.G. (2009) The relative cellular levels of CP2a and CP2b potentiates erythroid cell-specific expression of the α-globin gene by regulating the nuclear localization of CP2c. Biochem. Biophys. Res. Commun., 380, 813-817.
16. Uv,A.E., Thompson,C.R. and Bray,S.J. (1994) The Drosophila tissue-specific factor Grainyhead contains novel DNA-binding and dimerization domains which are conserved in the human protein CP2. Mol Cell Biol., 14, 4020-4031.
17. Shirra,M.K., Zhu,Q., Huang,H.C., Pallas,D. and Hansen,U. (1994) One exon of the human LSF gene includes conserved regions involved in novel DNA-binding and dimerization motifs. Mol. Cell Biol., 14, 5076-5087.
18. Shuai,K. and Liu,B. (2005) Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol., 5, 593-605.
19. Chung,C.D., Liao,J., Liu,B., Rao,X., Jay,P., Berta,P. and Shuai,K. (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science, 278, 1803-1805.
20. Liu,B., Liao,J., Rao,X., Kushner,S.A., Chung,C.D., Chang,D.D. and Shuai,K. (1998) Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA, 95, 10626-1031.
21. Schmidt,D. and Müller,S. (2003) PIAS/SUMO: new partners in transcriptional regulation. Cell. Mol. Life Sci., 60, 2561-2574.
22. Sharrocks,A.D. (2006) PIAS proteins and transcriptional regulation-more than just SUMO E3 ligases? Genes Dev., 20, 754-758.
23. O'Shea,J.J. and Watford,W. (2004) A peek at PIAS. Nat. Immunol., 5, 875-876.
24. Jackson,P.K. (2001) A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev., 15, 3053-3058.
25. Weger,S., Hammer,E. and Heilbronn,R. (2004) SUMO-1 modification regulates the protein stability of the large regulatory protein Rep78 of adeno associated virus type 2 (AAV-2). Virology, 330, 284-294.
26. Besnault-Mascard,L., Leprince,C., Auffredou,M.T., Meunier,B., Bourgeade,M.F., Camonis,J., Lorenzo,H.K. and Vazquez,A. (2005) Caspase-8 sumoylation is associated with nuclear localization. Oncogene, 24, 3268-3273.
27. Pichler,A. and Melchior,F. (2002) Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport. Traffic, 3, 381-387.
28. Kahyo,T., Nishida,T. and Yasuda,H. (2001) Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell, 8, 713-718.
29. Sachdev,S., Bruhn,L., Sieber,H., Pichler,A., Melchior,F. and Grosschedl,R. (2001) PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev., 15, 3088-3103.
30. Kotaja,N., Karvonen,U., Jänne,O.A. and Palvimo,J.J. (2002) PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol., 22, 5222-5234.
31. Girdwood,D.W., Tatham,M.H. and Hay,R.T. (2004) SUMO and transcriptional regulation. Semin. Cell Dev. Biol., 15, 201-210.
32. Ilmarinen,T., Kangas,H., Kytömaa,T., Eskelin,P., Saharinen,J., Seeler,J.S., Tanhuanpää,K., Chan,F.Y., Slattery,R.M., Alakurtti,K. et al. (2008) Functional interaction of AIRE with PIAS1 in transcriptional regulation. Mol. Immunol., 45, 1847-1862.
33. Diao,Y., Wang,X. and Wu,Z. (2009) SOCS1, SOCS3, and PIAS1 promote myogenic differentiation by inhibiting the leukemia inhibitory factor-induced JAK1/STAT1/STAT3 pathway. Mol. Cell Biol., 29, 5084-5093.
34. Forsberg,E.C., Downs,K.M., Christensen,H.M., Im,H., Nuzzi,P.A. and Bresnick,E.H. (2000) Developmentally dynamic histone acetylation pattern of a tissue-specific chromatin domain. Proc. Natl Acad. Sci. USA, 97, 14494-14499.
35. Chen,L.F. and Greene,W.C. (2003) Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J. Mol. Med., 81, 549-557.
36. Duma,D., Jewell,C.M. and Cidlowski,J.A. (2006) Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid Biochem. Mol. Biol., 102, 11-21.
37. Schwoebel,E.D. and Moore,M.S. (2000) The control of gene expression by regulated nuclear transport. Essays Biochem., 36, 105-113.
38. Kotaja,N., Karvonen,U., Jänne,O.A. and Palvimo,J.J. (2002) PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol., 22, 5222-5234.
39. Liu,B., Yang,R., Wong,K.A., Getman,C., Stein,N., Teitell,M.A., Cheng,G., Wu,H. and Shuai,K. (2005) Negative regulation of NF-kappaB signaling by PIAS1. Mol. Cell. Biol., 25, 1113-1123.
40. Kurihara,I., Shibata,H., Kobayashi,S., Suda,N., Ikeda,Y., Yokota,K., Murai,A., Saito,I., Rainey,W.E. and Saruta,T. (2005) Ubc9 and protein inhibitor of activated STAT 1 activate chicken ovalbumin upstream promoter-transcription factor I-mediated human CYP11B2 gene transcription. J. Biol. Chem., 280, 6721-6730.
41. Tolkunova,E., Malashicheva,A., Parfenov,V.N., Sustmann,C., Grosschedl,R. and Tomilin,A. (2007) PIAS proteins as repressors of Oct4 function. J. Mol. Biol., 374, 1200-1212.
42. Lee,H., Quinn,J.C., Prasanth,K.V., Swiss,V.A., Economides,K.D., Camacho,M.M., Spector,D.L. and Abate-Shen,C. (2006) PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein. Genes Dev., 20, 784-794.
43. Chae,J.H. and Kim,C.G. (2003) CP2 binding to the promoter is essential for the enhanced transcription of globin genes in erythroid cells. Mol. Cells, 15, 40-47.
44. Solis,C., Aizencang,G.I., Astrin,K.H., Bishop,D.E. and Desnick,R. (2001) Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria. J. Clin. Invest., 107, 753-762.
45. Kim,S., Ip,H.S., Lu,M.M., Clendenin,C. and Parmacek,M.S. (1997) A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Mol. Cell. Biol., 17, 2266-2278.
46. Li,L., Miano,J.M., Mercer,B. and Olson,E.N. (1996) Expression of the SM22 promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J. Cell Biol., 132, 849-859.
47. Mack,C.P. and Owens,G.K. (1999) Regulation of smooth muscle α-actin expression in vivo is dependent on CArG elements within the 5′ and first intron promoter regions. Circ. Res., 84, 852-861.
48. Yoshida,T., Kawai-Kowase,K. and Owens,G.K. (2004) Forced expression of myocardin is not sufficient for induction of smooth muscle differentiation in multipotential embryonic cells. Arterioscler. Thromb. Vasc. Biol., 24, 1596-1601.
49. Kawai-Kowase,K., Kumar,M.S., Hoofnagle,M.H., Yoshida,T. and Owens,G.K. (2005) PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins. Mol. Cell. Biol., 25, 8009-8023.